SEC Form 4
Septerna, Inc. (SEPN) insider trading
In the 12 months to Nov 18, 2026, 8 SEPN insiders reported open-market sales of $80.1M across 19 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $80.1M
- 19 filings · 8 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 17 of 19
- $16.6M of $80.1M sold (21%)
Who traded SEPN, and when
- Sale
- Sale, pre-arranged (10b5-1)
SEPN daily close from Nov 18, 2025 to Nov 17, 2026, between $21.69 and $52.34, last $40.02. 19 sale and 0 purchase filings by 8 insiders, marked at their filing dates. Peter Kolchinsky, Director: sold $31.7M across 1 filing, first filed Aug 14, 2026, last Aug 14, 2026. Rajeev M. Shah, Director: sold $31.7M across 1 filing, first filed Aug 14, 2026, last Aug 14, 2026. Third Rock Ventures GP V, LP, 10% owner: sold $7.4M across 1 filing, first filed Aug 14, 2026, last Aug 14, 2026. Alan Ezekowitz, Director: sold $3.9M across 1 filing, first filed Nov 13, 2026, last Nov 13, 2026. Samira Shaikhly, Chief People Officer: sold $2.8M across 5 filings, first filed Mar 4, 2026, last Jun 30, 2026. Elizabeth Bhatt, President and COO: sold $1.6M across 5 filings, first filed Feb 20, 2026, last Oct 19, 2026. 2 others: sold $895.3K across 5 filings, first filed Jun 24, 2026, last Sep 3, 2026.
Largest mark · tap a row for others
Peter Kolchinsky · Director
Sale $31,726,250
746,500 shares at $42.50 avg
Filed Aug 14, 2026 · traded Aug 12
Close on filing date $44.50
Peter Kolchinsky · Director
Director
$31.7M soldRajeev M. Shah · Director
Director
$31.7M soldThird Rock Ventures GP V, LP · 10% owner
10% owner
$7.4M soldAlan Ezekowitz · Director
Director
$3.9M soldSamira Shaikhly · Chief People Officer
Chief People Officer
$2.8M soldElizabeth Bhatt · President and COO
President and COO
$1.6M sold2 others
Combined, one mark per week
$895.3K soldOpen-market trades
19 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Peter Kolchinsky | Director | $31.7M | — | 1 | — | |
| Rajeev M. Shah | Director | $31.7M | — | 1 | — | |
| Third Rock Ventures GP V, LP | 10% owner | $7.4M | — | 1 | 100% of sales | |
| Alan Ezekowitz | Director | $3.9M | — | 1 | 100% of sales | |
| Samira Shaikhly | Chief People Officer | $2.8M | — | 5 | 100% of sales | |
| Elizabeth Bhatt | President and COO | $1.6M | — | 5 | 100% of sales | |
| Daniel D. Long | SVP, Drug Discovery | $888.1K | — | 4 | 100% of sales | |
| TRV GP VI, LLC | 10% owner | $7.2K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Alan Ezekowitz Director | SalePre-arranged (10b5-1) | 81,820 | $48.09 | $3.9M | 74,415 | |
traded | Elizabeth Bhatt President and COO | SalePre-arranged (10b5-1) | 4,000 | $37.41 | $149.6K | 177,115 | |
traded | Daniel D. Long SVP, Drug Discovery | SalePre-arranged (10b5-1) | 3,333 | $37.83 | $126.1K | 96,412 | |
traded | Third Rock Ventures GP V, LP 10% owner | SalePre-arranged (10b5-1) | 147,059 | $50.27 | $7.4M | 6,068,532 | |
traded | TRV GP VI, LLC 10% owner | SalePre-arranged (10b5-1) | 141 | $51.08 | $7.2K | 6,068,391 | |
traded | Rajeev M. Shah Director | Sale | 746,500 | $42.50 | $31.7M | 4,777,415 | |
traded | Peter Kolchinsky Director | Sale | 746,500 | $42.50 | $31.7M | 725,443 | |
traded | Elizabeth Bhatt President and COO | SalePre-arranged (10b5-1) | 25,000 | $44.00 | $1.1M | 174,209 | |
traded | Daniel D. Long SVP, Drug Discovery | SalePre-arranged (10b5-1) | 3,334 | $34.47 | $114.9K | 98,746 | |
traded | Elizabeth Bhatt President and COO | SalePre-arranged (10b5-1) | 4,000 | $33.99 | $136.0K | 174,209 | |
traded | Daniel D. Long SVP, Drug Discovery | SalePre-arranged (10b5-1) | 3,333 | $34.36 | $114.5K | 97,645 | |
traded | Samira Shaikhly Chief People Officer | SalePre-arranged (10b5-1) | 2,178 | $35.18 | $76.6K | 793 | |
traded | Daniel D. Long SVP, Drug Discovery | SalePre-arranged (10b5-1) | 15,000 | $35.51 | $532.6K | 96,412 | |
traded | Samira Shaikhly Chief People Officer | SalePre-arranged (10b5-1) | 6,250 | $35.08 | $219.2K | 793 | |
traded | Samira Shaikhly Chief People Officer | SalePre-arranged (10b5-1) | 5,935 | $28.93 | $171.7K | 5,028 | |
traded | Samira Shaikhly Chief People Officer | SalePre-arranged (10b5-1) | 11,798 | $30.06 | $354.7K | 793 | |
traded | Elizabeth Bhatt President and COO | SalePre-arranged (10b5-1) | 4,000 | $24.34 | $97.3K | 174,209 | |
traded | Samira Shaikhly Chief People Officer | SalePre-arranged (10b5-1) | 70,453 | $28.10 | $2.0M | 793 | |
traded | Elizabeth Bhatt President and COO | SalePre-arranged (10b5-1) | 4,000 | $28.97 | $115.9K | 174,209 |
GET /stocks/filings/vX/form-4?tickers=SEPN&filing_date.gte=2025-11-18&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"SEPN"
],
"issuer_cik": "0001984086",
"owner_cik": "0001780209",
"accession_number": "0001193125-26-461248",
"form_type": "4",
"filing_date": "2026-11-13",
"period_of_report": "2026-11-11",
"issuer_name": "Septerna, Inc.",
"issuer_trading_symbol": "SEPN",
"owner_name": "Ezekowitz Alan",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-11-11",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 13201,
"transaction_price_per_share": 47.0116,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 97280,
"transaction_value": 620600.1316,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 13, 2026."
},
{
"id": "F3",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.37 to $47.36. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
}
]
},
{
"tickers": [
"SEPN"
],
"issuer_cik": "0001984086",
"owner_cik": "0001780209",
"accession_number": "0001193125-26-461248",
"form_type": "4",
"filing_date": "2026-11-13",
"period_of_report": "2026-11-11",
"issuer_name": "Septerna, Inc.",
"issuer_trading_symbol": "SEPN",
"owner_name": "Ezekowitz Alan",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-11-11",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 31572,
"transaction_price_per_share": 48.7002,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 42843,
"transaction_value": 1537562.7144000002,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 13, 2026."
},
{
"id": "F5",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.37 to $49.33. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 21 records
- Option exercises21 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Septerna, Inc.'s CEO sold stock?
No. Jeffrey Finer (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is SEPN’s insider data?
These are SEPN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track SEPN insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SEPN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.